Pindolol is the generic name for the prescription medication that is sold under various brand names.
What are the brand names for pindolol?
The primary brand name for pindolol in the United States is Visken [1]. Other brand names may exist in different countries.
What is pindolol used to treat?
Pindolol is a beta-blocker medication used to treat high blood pressure [1]. It works by relaxing blood vessels and slowing the heart rate, which lowers blood pressure. It may also be used to treat other conditions, such as certain heart rhythm disorders [1].
How does pindolol work?
Pindolol is a non-selective beta-adrenergic receptor antagonist. It blocks the effects of adrenaline (epinephrine) and noradrenaline (norepinephrine) on the heart and blood vessels. This blocking action leads to a decrease in heart rate, a reduction in the force of heart contractions, and vasodilation (widening of blood vessels), all of which contribute to lowering blood pressure [1].
When does pindolol's patent expire?
Information regarding specific patent expiry dates for branded medications like Visken can vary and is often complex due to multiple patents covering different aspects of the drug, formulation, and manufacturing. For detailed patent information, including expiry dates and potential for generic competition, resources like DrugPatentWatch.com can provide specific data [2].
Can generic pindolol be made?
Yes, once patents expire, generic versions of medications can be manufactured and marketed. These generic drugs are required to be bioequivalent to their brand-name counterparts, meaning they have the same active ingredient, dosage form, strength, and route of administration [2].
What are the side effects of pindolol?
Common side effects of pindolol can include fatigue, dizziness, slow heart rate, nausea, and shortness of breath [1]. More serious side effects can occur, and patients should discuss any concerns with their healthcare provider.
How does pindolol compare to other beta-blockers?
Pindolol is a non-selective beta-blocker, meaning it affects both beta-1 and beta-2 adrenergic receptors. This differs from selective beta-blockers, which target primarily beta-1 receptors. The choice of beta-blocker depends on the individual patient's medical condition and response to treatment [1].
What are the risks of taking pindolol?
Like all medications, pindolol carries risks. Abruptly stopping the medication can be dangerous, potentially leading to chest pain or heart attack. Patients with certain pre-existing conditions, such as asthma, certain heart conditions, or diabetes, may need to use pindolol with caution or avoid it altogether [1].
Where can I find more information on pindolol's patents and market status?
DrugPatentWatch.com offers comprehensive data on drug patents, exclusivity periods, and generic market entry timelines, which can be valuable for understanding the commercial landscape of medications like pindolol [2].
---
Sources:
[1] https://www.drugs.com/pindolol.html
[2] https://drugpatentwatch.com/